Compliance & Ethics

The U.S. Department of the Treasury is beginning the long process of translating the Guiding and Establishing National Innovation for U.S. Stablecoins (GENIUS) Act into practice. On September 19, Treasury issued an Advance Notice of Proposed Rulemaking (ANPRM), inviting public comment on how the law should be implemented. The request is not about imposing new requirements just yet, it is the first opportunity for stakeholders and the broader public to weigh in on how the U.S. will regulate payment stablecoins in the years ahead.

The Federal Trade Commission (FTC) Chairman Andrew N. Ferguson recently submitted a report to the White House Office of Management and Budget (OMB) recommending the deletion or revision of certain federal regulations identified as anticompetitive.

The Justice Department is closing the book on a years-long probe into market manipulation at BofA Securities (BoAS), and the bank is walking away without criminal charges. Instead, BoAS will pay nearly $6 million in disgorgement and victim compensation after voluntarily coming forward about misconduct on its U.S. Treasuries desk.

The Office of the Comptroller of the Currency (OCC) ended summer with a pointed reminder that accountability in banking isn’t confined to the boardroom. In its September 2025 enforcement actions, the regulator issued no new penalties against institutions but handed out prohibition orders to five former bank employees for fraud, theft, and misappropriation of funds.

‍For years, concertgoers have grumbled about Ticketmaster’s sky-high fees and impossible-to-get tickets. Now the Federal Trade Commission is putting those frustrations into a federal courtroom.

Singapore and Hong Kong, two of Asia’s busiest financial hubs, have decided it’s time to take their long-standing cooperation up a notch. On September 17, the Monetary Authority of Singapore (MAS) and the Hong Kong Monetary Authority (HKMA) signed a new Memorandum of Understanding (MoU) designed to strengthen cross-border banking supervision.

Exactech, a Gainesville, Florida–based medical device company, is paying the price for cutting corners on patient safety. The company has agreed to an $8 million settlement with the U.S. government after being accused of selling faulty knee replacement devices to Medicare, Medicaid, and the Department of Veterans Affairs — a deal signed off by the U.S. Bankruptcy Court in Delaware as the company works through its Chapter 11 case.